AMEXDRUG CORP - FORM 10-K - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - April 2, 2013

Attached files

file filename
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORPexhibit31-1.htm
EX-10.13 - FIFTH AMENDMENT TO LEASE EXTENDING LEASE TERM (UNITS I & J) DATED FEBRUARY 20, 2013 - AMEXDRUG CORPexhibit10-13.htm
10-K - AMEXDRUG CORPORATION FORM 10 K - AMEXDRUG CORPamexdrug10k2012.htm
EXCEL - IDEA: XBRL DOCUMENT - AMEXDRUG CORPFinancial_Report.xls
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORPexhibit32-2.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORPexhibit31-2.htm
EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Amexdrug Corporation (the “Company”) on Form 10-K for the period ending December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jack Amin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 
(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Jack Amin ________________
Jack Amin
Chief Executive Officer
April 2, 2013
 

 

Stock widget

Investing forum

AMEXDRUG CORP Reports